Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19

BACKGROUND: Patients with cancer are presumed to have a higher risk to contract SARS-CoV-2 infection, because of their immunosuppressed status. The impact and course of COVID-19 infection in cancer patients receiving immunotherapy remains unknown. OBJECTIVES: To evaluate the safety of the management...

Descripción completa

Detalles Bibliográficos
Autores principales: Pala, Laura, Conforti, Fabio, Saponara, Maristella, De Pas, Tommaso, Giugliano, Federica, Omodeo Salè, Emanuela, Jemos, Costantino, Rubatto, Marco, Agostini, Andrea, Quaglino, Pietro, Fava, Paolo, Fierro, Maria Teresa, Queirolo, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413095/
https://www.ncbi.nlm.nih.gov/pubmed/32883537
http://dx.doi.org/10.1053/j.seminoncol.2020.07.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413095/
https://www.ncbi.nlm.nih.gov/pubmed/32883537
http://dx.doi.org/10.1053/j.seminoncol.2020.07.010

Ejemplares similares